baber/WOPTO huggingface dataset:
Patent FI-853131-A0 (FI)
Inventor: WEGMAN RICHARD WILLIAM
IPC: C07C51/56
Filed: 1985-08-15
Abstract: @ A process for the production of organic carboxylic anhydrides by the catalytic reaction of a methyl carboxylate and carbon monoxide in contact with a homogeneous catalyst system of rhodium metal atom, a phosphorus-containing ligand in which there is present at least one oxo (=0) oxygen atom attached to a phosphorus atom or a carbon atom to form a Z group and thegroup in said Z group is located at least one carbon atom removed and preferably from 2-4 carbon atoms removed from the phosphorus atom of the molecules represented by the formulasorand a halogen source, under mild reaction conditions, wherein R' is aryl, alKaryl, aralkyl or alkyl, and wherein 1 or more of said R' groups can be substituted with a Z group but not more than 3 of said R' groups in the molecule are so substituted; a is an integer from 0-4; b is an integer from 0-3 and Z is P(O)R'R'; - C(O)OR" or C(O)R", wherein R" is R or -H.
Patent FI-892582-A0 (FI)
Inventor: O'MARA ALPHONSUS
IPC: E06B5/16
Filed: 1989-05-26
Abstract: An element (10) for use as a door frame or part thereof comprises an intumescent strip (20) enclosed in a cured plastics material (11). The element (10) also comprises an element (22) of solid construction. In use, when the intumescent strip (20) is actuated to a temperature between 120<o>C and 300<o>C due to heat from a fire, it expands to a volume of at least six times its non-turgid state thereby sealing the element (10) to the fire door (30) and preventing the spread of fire to the other side of the door (30).
Patent FI-905591-A0 (FI)
Inventor: HOUGHTON MICHAEL
IPC: A61K39/12
Filed: 1990-11-12
Abstract: A pharmaceutical composition comprising a hepatitis C virus (HCV) antisense polynucleotide which is selectively hybridizable for the sense strand of the genome of an HCV, wherein the polynucleotide comprises a contiguous sequence of at least 8 nucleotides complementary to the sense strand of the genome of an HCV and a pharmaceutically acceptable excipient, wherein HCV is characterized by:  (i) a positive stranded RNA genome; (ii) said genome comprising an open reading frame (ORF) encoding a polyprotein; and (iii) said polyprotein is encoded by an HCV genome wherein the HCV genome has an homology at the polypeptide level of at least 40% to the 169 amino acid sequence shown in Figure 11.
Patent FI-915637-A0 (FI)
Inventor: COLSON WENDELL B
IPC: E06B9/388
Filed: 1991-11-29
Abstract: A retractable covering devices, in particular, light control window covering (30) including a lobed head (10) rail to prevent creasing and/or skewing of the window covering when rolled up, the head rail (10) having means (20,25) for attaching the window covering (30) which ensures proper alignment of the window covering (30). Also included are a bottom rear rail (40) having an anti-skewing device (48) which comprises a slidable weight (48) for compensating for skewed roll up; a flip-catch device (60) for preventing wrong-way roll up of the window covering; and a top-catch mechanism (62) for preventing both wrong-way roll up and over rotation in the proper roll up direction. <IMAGE>
Patent FI-923054-A0 (FI)
Inventor: HINZ FREDERICK PAUL
IPC: C08L9/00
Filed: 1992-07-01
Abstract: Vinyl monomer compositions having accelerated surface cure characteristics are described. These compositions are prepared from a vinyl monomer or monomer mixtures such as blend of isobornyl methacrylate and hydroxypropyl methacrylate, a bulk phase polymerization catalyst system, a polyvalent metal oxidative surface phase catalyst, and a diolefin rubber dispersed in the vinyl monomer as a surface cure accelerator. These compositions are useful as sealers, healers and for polymer concrete.
Patent FI-933728-A0 (FI)
Inventor: HOLMGREM JAN
IPC: A61P37/04
Filed: 1993-08-25
Abstract: Disclosed is a method of producing a vaccine composition against enteric infection caused by enterotoxigenic E. coli bacteria in humans. E. coli strains selected from different known strains each having the ability of expressing a certain type of colonization factor antigens are grown in a liquid culture medium. Finally formalin-killed E. coli strain having substantially preserved antigenic and hemagglutinating properties of said certain type of colonization factor antigens, is mixed with a pharmaceutically acceptable excipient and/or diluent. Further disclosed is a method of preventing an enteric infection caused by enterotoxigenic E. coli bacteria in humans, whereby a vaccine composition comprising inactivated E. coli strain is administered to a human being for the prevention of said infection.
Patent FI-935900-A0 (FI)
Inventor: DEWEER PHILIPPE
IPC: C12N15/09
Filed: 1993-12-28
Abstract: The invention relates to a heat-stable pullulanase, which has the property of hydrolysing glucosidic linkages of 1 alpha -6 type in amylopectin and which has enzymatic activity in acidic medium and at a temperature of approximately 60@C. The invention also relates to the microorganism strains producing this pullulanase and to the processes for the preparation of this pullulanase. The invention also relates to the uses of this pullulanase and the compositions comprising the latter. The invention also relates to a DNA molecule. The invention relates to an expression vector containing this DNA molecule and a chromosomic integration vector containing this DNA molecule. <IMAGE>
Patent FI-944658-A0 (FI)
Inventor: FLACH DIETER
IPC: G01N33/577
Filed: 1994-10-05
Abstract: PCT No. PCT/EP93/00981 Sec. 371 Date Jan. 17, 1995 Sec. 102(e) Date Jan. 17, 1995 PCT Filed Apr. 22, 1993 PCT Pub. No. WO93/22675 PCT Pub. Date Nov. 11, 1993A method is revealed for the quantitative determination of the proportion of the free form of a thyroid hormone ligand in a sample of a biological fluid in which the ligand is present partly in the free form and also partly in a form in which it is bound to physiological binding proteins. In the first step, a ligand derivative of the thyroid hormone with an immunoglobulin, a labelled specific binder, and a test tube whose walls are coated with an excess of a protein material are provided. In the second step, a sample of the biological fluid containing an unknown amount of the free thyroid hormone ligand, a solution containing a known amount of the ligand derivative, and a solution containing a known, less than stoichiometric amount of the labelled specific binder are added to the test tube to form a liquid reaction mixture. In the third step, the reaction mixture is incubated to allow the free thyroid hormone ligand and the ligand derivative in the liquid reaction mixture to compete for the binding sites of the labelled specific binder, and to allow, in a concomitant slower reaction, the binding of the immunoglobulin part of the ligand derivative to the excess of the protein material on the walls of the test tube. In the fourth step, the remaining liquid reaction mixture is removed from the test tube. In the final steps, the amount of labelled specific binder bound to the walls of the test tube is determined and the amount of the free thyroid hormone ligand calculated.
Patent FI-951952-A0 (FI)
Inventor: ROHDE WOLFGANG
IPC: B24B47/02
Filed: 1995-04-25
Abstract: The grinding device has a guide (7) running parallel to the roller (16) to be ground. A grinding member (8) is mounted on this roller and is movable along it by a displacement drive (13). It is adjustable against the roller by an adjustment drive (5). For the guide a rotary drive (10) is provided, which sets the guide in rotary movement around its longitudinal axis. The grinding member is formed by a rotation symmetrical grinding unit and is non-rotatively connected to the guide. The guide is formed as a hollow shaft (7'), and the grinding member works in conjunction with a driver (15), which extends through a slot in the hollow shaft. <IMAGE>
Patent FI-952005-A0 (FI)
Inventor: LIN SZU-MIN
IPC: C01B15/01
Filed: 1995-04-27
Abstract: An apparatus and process for hydrogen peroxide vapor sterilization of medical instruments and similar devices make use of hydrogen peroxide vapor released from a substantially non-aqueous organic hydrogen peroxide complex, such as a urea-peroxide complex. Optionally, a plasma can be used in conjunction with the vapor. A method for preparing substantially non-aqueous hydrogen peroxide complexes is also provided. These complexes are useful as a source of peroxide vapor in hydrogen peroxide vapor sterilizers and as a component of self-sterilizing packaging materials. <IMAGE>
Patent FI-956321-A0 (FI)
Inventor: HANES ROGER BRIAN
IPC: G06F9/44
Filed: 1995-12-29
Abstract: A system for generating instructions down-loadable onto an applications platform, such as a speech applications platform. Instructions are defined by a plurality of parameter dependent operations, identified as blocks, which are linked together to specify an applications topology. Before parameters are entered, the validity of the skeleton of linked blocks is validated. Parameters are then added after a skeleton has passed a validity test. After parameters have been entered, so as to define the complete system, simulation is performed, including speech simulation. Simulation may be performed on a development platform or on a speech applications platform. A block may define a call to an external routine. The originally defined system is automatically converted into down-loadable instructions. The down-loadable instructions also include the call to the external routine, so that said routine may be called during on-line operation. Alternatively, stub blocks are included that allow C code to be embedded within down-loadable code.
Patent IL-63047-A0 (IL)
Title: 5-aroyl-6-chloro-(or bromo)-1,2-dihydro-3h-pyrrolo(1,2a)pyrrole-7-carboxylic acids and esters and salts thereof,their production and pharmaceutical compositions containing them
IPC: C07D207/32
Filed: 1981-06-05
Abstract: Novel 5-aroyl-6-chloro- or 6-bromo-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-7-carboxylic acids represented by the formula  <IMAGE>  and the pharmaceutically acceptable, non-toxic esters and salts thereof, wherein Y is chloro or bromo and Ar is an optionally substituted phenyl, 2-furyl, or 2-thienyl ring or a 3-furyl, 3-thienyl, 2-pyrrolyl or 1-alkyl-2-pyrrolyl ring. These compounds are useful as anti-inflammatory, analgesic and antipyretic agents and as smooth muscle relaxants.
Patent IL-77049-A0 (IL)
Title: Isolation and culture of adrenal medullary endothelial cells producing blood clotting factor viii:c
IPC: C12N5/00
Filed: 1985-11-14
Abstract: The present invention discloses a new line of endothelial cell of adrenal medullary origin capable of producing blood clotting Factor VIII:C. A method of isolating and culturing said cell line has also been disclosed. Factor VIII:C is useful in treating hemophilia.
Patent IL-84205-A0 (IL)
Title: Core-shell polymers and compositions containing them
IPC: C08L25/10
Filed: 1987-10-19
Abstract: A core/shell polymer comprises a rubbery core of crosslinked, conjugated diolefin polymer or copolymer with 0 or upto 50%, based on the total core weight, of a first vinyl monomer copolymerized with the diolefin, and one or more polymer shells, at least one of which shells is a vinylaromatic polymer or copolymer, the particles further having an average particle diameter no more than 250 nanometers and toluene swell index of from 13 to 45, preferably from 15 to 25. The core/shell polymers are useful for modifying the properties of olefinic, aromatic addition and/or condensation resins, particularly poly(styrene).
Patent IL-86209-A0 (IL)
Title: Synthesis of cisplatin analogs
IPC: A61P35/00
Filed: 1988-04-28
Abstract: This disclosure sets forth a novel process for producing cisplatin analogs which possess antitumor activity.
Patent IL-93225-A0 (IL)
Title: Phenylsulphone derivatives
IPC: C07C317/14
Filed: 1990-01-30
Abstract: The invention discloses a novel aminophenylsulphone derivative (and its salts) which is an inhibitor of the enzyme aldose reductase, pharmaceutical compositions containing the novel derivative, and processes for its manufacture. The invention also discloses certain novel N-acyl derivatives of the aminophenylsulphone derivative, which are useful in the production of the latter derivative.
Patent FI-20002646-A0 (FI)
Inventor: HOLMA MAUNU
IPC: H04Q11/04
Filed: 2000-12-01
Abstract: This invention relates to the multiplexing of multiple sources in a multiplexer. A special arrangement is used for calculating an efficient peak capacity value that guarantees good performance for an outgoing link. The invention uses a method with two phases. The first phase precalculates the capacity of the outgoing link with different numbers of incoming links having equal packet size, and forms a table from the results of the precalculation. In the second phase, the peak capacity needed for the outgoing link is calculated using the precalculated tables.
Patent FI-20021600-A0 (FI)
Inventor: PINCHASIK GREGORY
IPC: A61M29/00
Filed: 2002-09-06
Abstract: A stent is made up of a plurality of adjacent stent segments (2), spaced from one another. Between each two adjacent stent segments is a detachment zone (3) that includes two articulation planes. In each articulation plane there are two connecting members (315), with the members in one articulation plane spaced from those in the other articulation plane about the circumference of the stent by from about 60 to 140 degrees from each other. Within each articulation plane, the two members ne are spaced between about 140 and 220 degrees from each other. <IMAGE>
Patent FI-20105071-A0 (FI)
Inventor: GRITZKO TORSTEN
Filed: 2010-01-27
Abstract: The valve unit (23) has a base body (11) made of steel, and the base body holds a continuous pressure-relief valve (15) in an opening (14). The continuous pressure-relief valve has an actuating element (20) loaded by a spring element (19), which actuates a valve ball (21) of the continuous pressure-relief valve against a valve seat (24) of the continuous pressure-relief valve. The valve seat of the continuous pressure-relief valve is formed by a separate insert (25) made of steel.
Patent IL-101665-A0 (IL)
Title: Merocyanine protein error indicators
IPC: G01N33/52
Filed: 1992-04-21
Abstract: The present invention provides a merocyanine protein error indicator compound. Merocyanine compounds are a new class of protein error indicators, providing an analytical tool useful in the detection of protein in a sample.
Patent IL-109151-A0 (IL)
Title: Pharmaceutical preparations for the treatment of skin disorders
IPC: A61K31/41
Filed: 1994-03-29
Abstract: A compound of the formula I or II <CHEM> and physiologically tolerable salts of compound of the formula II are suitable for treatment of psoriasis.
Patent IL-109396-A0 (IL)
Title: Pyrido (1,2,3-DE) quinoxaline derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof
IPC: C07F9/6558
Filed: 1994-04-22
Abstract: PCT No. PCT/DE94/00494 Sec. 371 Date Dec. 27, 1995 Sec. 102(e) Date Dec. 27, 1995 PCT Filed Apr. 28, 1994 PCT Pub. No. WO94/25472 PCT Pub. Date Nov. 10, 1994Pyrido[1,2,3-de]quinoxaline derivatives of formula I    <IMAGE>  (I)  in which R1, R2 and R3 each mean hydrogen, -POXY, halogen or -COR, R4 means hydrogen or OH, R5, R6 and R7 are the same or different and mean hydrogen, halogen, nitro, NR12R13, cyano, CF3, C1-6 alkyl, C1-4 alkoxy, or R5 and R6 or R6 and R7 represent a fused benzene ring, and means a single or double bond, are described as well as their production and use in pharmaceutical agents.
Patent IL-114311-A0 (IL)
Title: Detachable multi-coil delivery catheter
IPC: A61B17/12
Filed: 1995-06-25
Abstract: This invention is a surgical instrument, and specifically is a device for delivering embolic coils to a selected site within the vasculature of a human body. This instrument uses, and may include, the catheter used to place the embolic coil. In particular, the device is made up of a pusher wire having a distal tip which is configured to engage the proximal end of an embolic coil. The device may also include a cylindrical pusher which coaxially surrounds at least a portion of the pusher wire and cooperates in the disengagement of the coil from the pusher wire and the ejection of the vasoocclusive coil into the selected vascular site. The pusher wire's engagement tip may be of any selected and convenient shape, and may be grooved, if so desired, to enhance the engagement joint strength.
Patent IL-122826-A0 (IL)
Title: Prostane derivatives and the combination thereof with antibiotics in the treatment of bacterial infections
IPC: A61K31/558
Filed: 1996-08-06
Abstract: PCT No. PCT/EP96/03481 Sec. 371 Date Apr. 23, 1998 Sec. 102(e) Date Apr. 23, 1998 PCT Filed Aug. 6, 1996 PCT Pub. No. WO97/06806 PCT Pub. Date Feb. 27, 1997A method is described for treating bacterially induced meningitis, comprising administering a prostane derivative of formula I or Ia wherein X1, X2, X3, X4, X5, R1, R2, R3 and R4 are as described below, and the -O-R3- group is in the  alpha - or  beta -configuration. The prostane derivative can optionally comprise or serve as an adjuvant, and it can be administered in combination with an antiobiotic.
Patent IL-124109-A0 (IL)
Title: 2-alkylpyrrolidines
IPC: A61K31/401
Filed: 1996-09-06
Abstract: (2R,3R,4R)-3,4-dihydroxy-2-hydroxymethylpyrrolidine and other substituted 2-methylpyrrolidines can be used for the treatment of diabetes.
Patent IL-127891-A0 (IL)
Title: Chimeric heteromultimeter adhesins
IPC: C07K19/00
Filed: 1997-07-08
Abstract: Novel chimeric heteromultimer adhesins that bind the ligand of natural heteromultimeric receptors and uses therefor are disclosed. The chimeric molecules of the heteromultimer adhesins comprise an extracellular domain of a heteromultimeric receptor monomer and a multimerization domain for the stable interaction of the chimeric molecules in the adhesin. Specifically disclosed are heteromultimeric adhesins comprising the extracellular domains of ErbB2 and ErbB3 or ErbB2 and ErbB4. The chimeric ErbB heteromultimer adhesins of the present invention are useful as competitive antagonists or agonists of a neuregulin for the treatment of diseases such as various cancers.
Patent IL-131170-A0 (IL)
Title: Modified polyesters and methods for the preparation thereof
IPC: C08K5/05
Filed: 1998-01-30
Abstract: A polymer blend comprising a polyester, a polyfunctional acid anhydride wherein said polyfunctional acid anhydride has a functionality as described herein of three or more, and a polyhydric alcohol or precursor thereto wherein said polyhydric alcohol has a functionality of three or more, and wherein said molar ratio of said polyfunctional acid anhydride to the polyhydric alcohol or precursor thereto is in the range of 0.5:1 to (10xC):1, where C is the number of moles of alcohol or equivalent in the polyhydric alcohol or precursor thereto.
Patent IL-141423-A0 (IL)
Title: Hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereof
IPC: C07F9/38
Filed: 1999-08-27
Abstract: New hydrate forms of alendronate sodium, having water content of between about one and about twelve percent, and processes for their manufacture, are disclosed. New crystalline forms of alendronate sodium B, D, E, F, G and H, and processes for manufacturing them, are also disclosed. These new forms of alendronate sodium are suitable for incorporation into pharmaceutical compositions for combating bone resorption in bone diseases.
Patent IL-145606-A0 (IL)
Title: Integrity check in a communication system
IPC: H04W12/00
Filed: 2001-01-23
Abstract: A node is disclosed for use in a system comprising said node (6) and a further node (20). A plurality of different communication channels are provided between said nodes, each communication channel having a different identity. The node comprises means for calculating an authentication code (XMAC-I) from a plurality of values. Some of said values are the same for said plurality of different communication channels, while at least one of said values being arranged to comprise information relating to the identity of a communication channel (RB ID) of said plurality of communication channels. The node further comprises means for receiving information relating to an authentication code (MAC-I) calculated by said further node, and means for comparing information relating to an authentication code (XMAC-I) calculated by said node with information relating to an authentication code (MAC-I) calculated by the further node. <IMAGE>
Patent IL-148010-A0 (IL)
Title: Guard bed containing lead compounds upstream of a bed of copper-containing catalyst to prevent its contamination by chlorine and sulphur contaminants
IPC: B01J33/00
Filed: 2000-08-11
Abstract: A combination comprising a bed of a particulate copper-containing catalyst and, a guard bed of a particulate composition containing a) lead and/or at least one lead compound that reacts with hydrogen chloride and b) a support therefor. The lead compound is preferably lead nitrate. The combination is of particular utility for the low temperature shift reaction wherein carbon monoxide is reacted with steam to produce hydrogen and carbon dioxide.
Patent IL-153353-A0 (IL)
Title: Method of placing fibers into channels of a mold and fiber placement head for accomplishing same
IPC: B29C70/38
Filed: 2000-06-13
Abstract: A method and fiber-placement head are provided for placing fibers (33) into a plurality of channels (11) of a mold (10) to form the ribs of a structural member, including panels, cylinders and cones, or even a ribbed latticework structure by itself. While providing relative movement between the mold (10) and a plurality of fiber placement heads (22), fibers (33) are simultaneously placed into a number of the channels (11) of a mold (10) by means of the heads (22). The relative movement and placement is repeated as often as necessary in order to dispose into the channels (11) a desired thickness of the fibers (33). Each head (22) has a single motor-driven wheel (37) for continuously withdrawing the fibers (33) from a supply means (26) and feeding the fibers (33) through the head (22).
Patent IL-159160-A0 (IL)
Title: Paving unit
IPC: E01C5/00
Filed: 2001-07-06
Abstract: A interlocking paving unit has a top surface ( 2 ) and a plurality of side surfaces ( 4, 5 ), with at least one of the side surfaces ( 4, 5 ) of the paving unit being provided with at least one substantially vertically extending, substantially asymmetric protrusion ( 10 ). The protrusion ( 10 ) comprises a first ridge portion ( 11 ) and a second portion ( 12 ) being spaced apart by an intermediate portion ( 13 ). The protrusion ( 10 ) is locatable in a complementary recess on an adjacent paving unit, wherein the interengagement between the protrusion and the recess provides interlock between the paving unit and an adjacent paving unit.
Patent IL-165350-A0 (IL)
Title: Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue
IPC: A61P9/10
Filed: 2003-06-05
Abstract: Described is the use of a microorganism or cell containing a DNA sequence encoding a detectable protein or a protein capable of inducing a detectable signal, e.g., a luminescent or fluorescent protein for the preparation of a diagnostic composition for diagnosis and/or visualization of wounded or inflamed tissue or a disease associated therewith. Moreover, therapeutic uses are described, wherein said microorganism or cell additionally contain an expressible DNA sequence encoding a protein suitable for therapy, e.g. an enzyme causing cell death or digestion of debris. <IMAGE>